XML 127 R113.htm IDEA: XBRL DOCUMENT v3.8.0.1
Other Charges, Net - Restructuring Plans (Details)
$ in Millions
12 Months Ended
Dec. 31, 2017
USD ($)
employee
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Restructuring charges      
Restructuring expenses $ 16.2 $ 20.8 $ 29.3
Restructuring initiative within Bruker CALID and Bruker Nano Groups      
Restructuring charges      
Expected reduction in number of employees | employee 125    
Restructuring expenses $ 7.0 10.4  
Restructuring initiative within Bruker CALID and Bruker Nano Groups | Cost of revenues      
Restructuring charges      
Restructuring expenses 4.0 6.8  
Restructuring initiative within Bruker CALID and Bruker Nano Groups | Other charges, net      
Restructuring charges      
Restructuring expenses 3.0 3.6  
Restructuring initiative within Bruker CALID and Bruker Nano Groups | Severance and Exit Costs      
Restructuring charges      
Restructuring expenses 6.5 7.8  
Restructuring initiative within Bruker CALID and Bruker Nano Groups | Severance and Exit Costs | Cost of revenues      
Restructuring charges      
Restructuring expenses 3.5 4.4  
Restructuring initiative within Bruker CALID and Bruker Nano Groups | Severance and Exit Costs | Other charges, net      
Restructuring charges      
Restructuring expenses 3.0 3.4  
Restructuring initiative within Bruker CALID and Bruker Nano Groups | Inventory Writedown and Asset Impairment      
Restructuring charges      
Restructuring expenses 0.5 2.6  
Restructuring initiative within Bruker CALID and Bruker Nano Groups | Inventory Writedown and Asset Impairment | Cost of revenues      
Restructuring charges      
Restructuring expenses $ 0.5 2.4  
Restructuring initiative within Bruker CALID and Bruker Nano Groups | Inventory Writedown and Asset Impairment | Other charges, net      
Restructuring charges      
Restructuring expenses   0.2  
Restructuring initiative within Bruker BioSpin Group      
Restructuring charges      
Reduction in employee headcount (as a percent) 9.00%    
Restructuring expenses $ (2.7) 3.3 16.2
Restructuring initiative within Bruker BioSpin Group | Cost of revenues      
Restructuring charges      
Restructuring expenses (2.7) 2.2 12.3
Restructuring initiative within Bruker BioSpin Group | Other charges, net      
Restructuring charges      
Restructuring expenses   1.1 3.9
Restructuring initiative within Bruker BioSpin Group | Severance and Exit Costs      
Restructuring charges      
Restructuring expenses (2.7) 3.3 12.0
Restructuring initiative within Bruker BioSpin Group | Severance and Exit Costs | Cost of revenues      
Restructuring charges      
Restructuring expenses (2.7) 2.2 10.2
Restructuring initiative within Bruker BioSpin Group | Severance and Exit Costs | Other charges, net      
Restructuring charges      
Restructuring expenses   1.1 1.8
Restructuring initiative within Bruker BioSpin Group | Inventory Writedown and Asset Impairment      
Restructuring charges      
Restructuring expenses     4.2
Restructuring initiative within Bruker BioSpin Group | Inventory Writedown and Asset Impairment | Cost of revenues      
Restructuring charges      
Restructuring expenses     2.1
Restructuring initiative within Bruker BioSpin Group | Inventory Writedown and Asset Impairment | Other charges, net      
Restructuring charges      
Restructuring expenses     2.1
Other programs      
Restructuring charges      
Restructuring expenses 11.9 7.1 13.1
Other programs | Cost of revenues      
Restructuring charges      
Restructuring expenses 4.3 2.0 8.9
Other programs | Other charges, net      
Restructuring charges      
Restructuring expenses $ 7.6 $ 5.1 $ 4.2